Storage and regulated secretion of factor VIII in blood outgrowth endothelial cells.

Haematologica 2009 May 31;94(5):670-8. Epub 2009 Mar 31.

Department of Plasma Proteins, Sanquin Research, Plesmanlaan 125, Amsterdam, The Netherlands.

Background: Gene therapy provides an attractive alternative for protein replacement therapy in hemophilia A patients. Recent studies have shown the potential benefit of directing factor (F)VIII gene delivery to cells that also express its natural carrier protein von Willebrand factor (VWF). In this study, we explored the feasibility of blood outgrowth endothelial cells as a cellular FVIII delivery device with particular reference to long-term production levels, intracellular storage in Weibel-Palade bodies and agonist-induced regulated secretion.

Design And Methods: Human blood outgrowth endothelial cells were isolated from peripheral blood collected from healthy donors, transduced at passage 5 using a lentiviral vector encoding human B-domain deleted FVIII-GFP and characterized by flow cytometry and confocal microscopy.

Results: Blood outgrowth endothelial cells displayed typical endothelial morphology and expressed the endothelial-specific marker VWF. Following transduction with a lentivirus encoding FVIII-GFP, 80% of transduced blood outgrowth endothelial cells expressed FVIII-GFP. Levels of FVIII-GFP positive cells declined slowly upon prolonged culturing. Transduced blood outgrowth endothelial cells expressed 1.6+/-1.0 pmol/1 x 10(6) cells/24h FVIII. Morphological analysis demonstrated that FVIII-GFP was stored in Weibel-Palade bodies together with VWF and P-selectin. FVIII levels were only slightly increased following agonist-induced stimulation, whereas a 6- to 8-fold increase of VWF levels was observed. Subcellular fractionation revealed that 15-22% of FVIII antigen was present within the dense fraction containing Weibel-Palade bodies.

Conclusions: We conclude that blood outgrowth endothelial cells, by virtue of their ability to store a significant portion of synthesized FVIII-GFP in Weibel-Palade bodies, provide an attractive cellular on-demand delivery device for gene therapy of hemophilia A.

Download full-text PDF

Source
http://dx.doi.org/10.3324/haematol.13427DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2675679PMC
May 2009
8 Reads

Publication Analysis

Top Keywords

blood outgrowth
28
outgrowth endothelial
28
endothelial cells
28
weibel-palade bodies
12
cells
9
endothelial
8
blood
8
gene therapy
8
transduced blood
8
therapy hemophilia
8
delivery device
8
cells expressed
8
outgrowth
7
fviii-gfp
6
fviii
5
encoding fviii-gfp
4
fviii-gfp 80%
4
80% transduced
4
storage regulated
4
lentivirus encoding
4

Similar Publications